NCT03020433View on ClinicalTrials.gov

Novel Brain Stimulation Therapies in Stroke Guided Expressions of Plasticity

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
StrokeCerebrovascular DisordersNervous System DiseasesBrain DiseasesCardiovascular DiseasesVascular DiseasesCentral Nervous System Diseases
Interventions
DEVICE

rTMS Contralesional M1

1Hz Contalesional M1 repetitive transcranial magnetic stimulation (1500 pulses, 25 minutes, 90% AMT

DEVICE

rTMS Contralesional PMC

5Hz Contralesional PMC repetitive transcranial magnetic stimulation (1500 pulses, 10 minutes, 5 trains of 300 pulses each with 1 minute rest in between, 90% AMT)

DEVICE

rTMS Ipsilesional PMC

5HZ Ipsilesional PMC repetitive transcranial magnetic stimulation (1500 pulses, 10 minutes, 5 trains of 300 pulses each with 1 minute rest in between, 90% AMT)

DEVICE

rTMS sham at Ipsilesional M1

1Hz Ipsilesional M1 sham repetitive transcranial magnetic stimulation (1500 pulses, 25 minutes, 50% MSO)

Trial Locations (1)

44195

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT03020433 - Novel Brain Stimulation Therapies in Stroke Guided Expressions of Plasticity | Biotech Hunter | Biotech Hunter